Adjuvant-induced arthritis is a relevant model to mimic coronary and myocardial impairments in rheumatoid arthritis - 11/02/21
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 7 |
| Iconographies | 3 |
| Vidéos | 0 |
| Autres | 0 |
Highlights |
• | The AIA model mimics multiple aspects of cardiac abnormalities observed in RA. |
• | ET-1 and Ang-II level correlated with coronary dysfunction and cardiac hypertrophy. |
• | Arthritis is associated with an exaggerated susceptibility to ischemic injury. |
• | AIA is a relevant model to unravel the mechanisms involved in cardiac impairments. |
Abstract |
Objectives |
To determine if the adjuvant-induced arthritis model reproduced coronary and cardiac impairments observed in rheumatoid arthritis patients. The link between disease activity and circulating levels of angiotensin II and endothelin-1 have been studied, as well as the myocardial susceptibility to ischemia.
Methods |
At the acute inflammatory phase, coronary reactivity was assessed in isolated arteries, and cardiac function was studied in isolated perfused hearts, before and after global ischemia/reperfusion. Ischemic insult was evaluated by the infarct size, lactate dehydrogenase and creatine phosphokinase levels in coronary effluents. Cardiac myeloperoxidase activity was measured, as well as angiotensin II and endothelin-1 levels.
Results |
Compared to controls, adjuvant-induced arthritis had reduced coronary Acetylcholine-induced relaxation associated with cardiac hypertrophy, both being correlated with plasma levels of endothelin-1 and angiotensin II, and arthritis score. Although cardiac function at baseline was similar from controls, adjuvant-induced arthritis rats exhibited lower cardiac functional recovery, increased myeloperoxidase activity, higher infarct size and creatine phosphokinase levels after ischemia/reperfusion.
Conclusions |
The adjuvant-induced arthritis model displays coronary endothelial dysfunction associated with myocardial hypertrophy and a reduced tolerance to ischemia. This model might be useful for deciphering the pathophysiology of cardiac dysfunction in rheumatoid arthritis and paves the way for studying the role of endothelin-1 and angiotensin II.
Le texte complet de cet article est disponible en PDF.Keywords : Adjuvant-induced arthritis, Coronary dysfunction, Heart dysfunction, Ischemia/reperfusion
Plan
Vol 88 - N° 1
Article 105069- janvier 2021 Retour au numéro
Article précédent
- Bone changes in early inflammatory arthritis assessed with High-Resolution peripheral Quantitative Computed Tomography (HR-pQCT): A 12-month cohort study
- Scott Cameron Brunet, Stephanie Finzel, Klaus Engelke, Steven Kyle Boyd, Cheryl Barnabe, Sarah Lynn Manske
- Opioid epidemic: Does rheumatological practice favors risk for patients? National survey on rheumatologists’ opioid prescriptions and compliance to guidelines for strong opioid prescription
- Anne-Priscille Trouvin, Chouki Chenaf, Marie Riquelme, Emmanuel Curis, Ioannis Nicolis, Rose-Marie Javier, Pascale Vergne-Salle, Françoise Laroche, Sophie Pouplin, Nicolas Authier, Serge Perrot
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?